Nuclear Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Clin Rheumatol. 2012 Jun;31(6):961-6. doi: 10.1007/s10067-012-1963-y. Epub 2012 Feb 24.
Prognosis of systemic sclerosis (SSc) depends on internal organ involvement. We assessed the value of renal function reserve (RFR) for the detection of preclinical nephropathy in scleroderma. Thirty SSc patients with normal serum creatinine and 30 healthy controls were included. Medsger disease severity score, glomerular filtration rate (GFR), and microalbuminuria were measured. Tc-99m DTPA was utilized for GFR measurement at baseline and after oral protein overload (stimulated GFR). RFR was calculated as the percentile increase of stimulated GFR. SSc patients had lower means of baseline GFR (P=0.001), stimulated GFR (P=0.004), RFR (P=0.046), and higher microalbuminuria (P=0.009) than controls. According to baseline GFR, SSc patients showed three categories-normal baseline GFR (n=12), hyperfiltration GFR (n=3), and reduced baseline GFR (n=15). In the former category, RFR was normal in 6/12 patients and abnormal in the remainders (50%). Hyperfiltration patients and those with reduced baseline GFR showed abnormal RFR. A statistically significant negative association was found between microalbuminuria versus stimulated GFR and RFR (r= -0.5, P=0.007 and r= -0.45, P=0.013, respectively). The majority of SSc patients with abnormal RFR had disease duration of ≥48 months (60% vs. 20%, P=0.008). All SSc patients with pulmonary hypertension had abnormal RFR, while reduced baseline GFR was noted in only 60%. A significant negative correlation was found between reduced baseline GFR and cumulative dose of corticosteroids in SSc patients (r= -0.4, P=0.022). RFR estimation could be a useful predictive marker for preclinical renal involvement in SSc patients so that early prophylactic measures and therapy modifications could be considered.
系统性硬化症 (SSc) 的预后取决于内脏器官受累情况。我们评估了肾功能储备 (RFR) 在检测硬皮病临床前肾病中的价值。纳入 30 例血清肌酐正常的 SSc 患者和 30 例健康对照者。测量了 Medsger 疾病严重程度评分、肾小球滤过率 (GFR) 和微量白蛋白尿。基线和口服蛋白负荷后 (刺激 GFR) 时使用 Tc-99m DTPA 测量 GFR。RFR 计算为刺激 GFR 的百分位增加。SSc 患者的基线 GFR (P=0.001)、刺激 GFR (P=0.004)、RFR (P=0.046) 均值较低,微量白蛋白尿较高 (P=0.009)。根据基线 GFR,SSc 患者分为三组:正常基线 GFR (n=12)、高滤过 GFR (n=3) 和低基线 GFR (n=15)。在前一组中,12 例患者中有 6 例 RFR 正常,其余患者 (50%) 异常。高滤过患者和低基线 GFR 患者的 RFR 异常。微量白蛋白尿与刺激 GFR 和 RFR 呈显著负相关(r=-0.5,P=0.007 和 r=-0.45,P=0.013)。异常 RFR 的大多数 SSc 患者的疾病持续时间≥48 个月 (60% vs. 20%,P=0.008)。所有肺动脉高压的 SSc 患者均有异常 RFR,而只有 60% 的患者有低基线 GFR。SSc 患者中,低基线 GFR 与皮质类固醇累积剂量呈显著负相关(r=-0.4,P=0.022)。RFR 估计可能是 SSc 患者临床前肾脏受累的有用预测标志物,以便考虑早期预防性措施和治疗改变。